Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Consumer Health Regulation: Before Warning, Recall For Supplement With COVID-19 Label Claim

Jun 28 2020

• By Malcolm Spicer

Attention Please_1014394012_1200.jpg

Related Content

Like Health And Economic Impact, COVID-19 Unprecedented As Unlawful Claims Driver

Apr 24 2020

Additional Topics

United States US States Puerto Rico Dietary Supplements OTC Drugs Recalls FDA Coronavirus COVID-19 Advertising, Marketing & Sales Commercial Companies Compliance Distribution Ingredients Manufacturing Policy Regulation Safety Consumer

More from Recalls

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.